If you need more lookups,
subscriptions start at $34 USD/month.
David Spackman Location
Milton Keynes, GB
David Spackman Work
General Manager, Jazz Pharmaceuticals Nordics @ (February 2025 - Present)
VP, Head of Marketing, Europe and International @ (October 2022 - February 2025)
VP, Business Unit Head, Sleep and Neuroscience Asset Pipeline, Europe and International @ (May 2021 - September 2022)
Executive Director, Business Unit Head Neuroscience, EU and RoW @ (June 2020 - April 2021)
Senior Marketing Director, EU and RoW Sleep BU @ (June 2019 - June 2020)
Business Unit Director - Cardiovascular, Renal, Metabolic @ (January 2017 - March 2019)
Commercial Head for Brilinta (Acute care); Global Products and Portfolio Strategy @ (August 2015 - December 2016)
Senior Marketing Director, Cardiovascular and Metabolic; AstraZeneca Japan @ (May 2013 - July 2015)
Head of Payer Evidence @ (January 2013 - May 2013)
Head of Cardiovascular Marketing @ (April 2010 - December 2012)
Business Manager, East of England @ (June 2009 - March 2010)
Respiratory Marketing Manager, COPD @ (April 2007 - June 2009)
Senior Brand Manager, Anti-infectives @ (November 2006 - April 2007)
Area Sales Manager, South Essex @ (February 2005 - November 2006)
Brand Manager and Senior Brand Manager roles (Gastrointestinal, Oncology, Cardiovascular) @ (May 2001 - January 2005)
Purchasing Buyer @ (May 2000 - May 2001)
GP Sales Representative and Oncology Hospital Sales Representative roles @ (January 1999 - April 2000)
Market Research Executive @ (October 1997 - December 1998)
David Spackman Education
University of Bristol
BSc (Hons) 1st class (Physiology)
David Spackman Summary
David Spackman, based in Milton Keynes, GB, is currently a General Manager, Jazz Pharmaceuticals Nordics at Jazz Pharmaceuticals. David Spackman brings experience from previous roles at Jazz Pharmaceuticals. David Spackman holds a BSc (Hons) 1st class in Physiology @ University of Bristol. David Spackman has 1 emails on RocketReach.
Looking for a different David Spackman?
Find contact details for 700 million professionals.